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KPN03535 (gi|152972051) is a putative lipoprotein of unknown function that is
secreted by Klebsiella pneumoniae MGH 78578. The crystal structure reveals
that despite a lack of any detectable sequence similarity to known structures, it is
a novel variant of the OB-fold and structurally similar to the bacterial Cpx-
pathway protein NlpE, single-stranded DNA-binding (SSB) proteins and toxins.
K. pneumoniae MGH 78578 forms part of the normal human skin, mouth and
gut ﬂora and is an opportunistic pathogen that is linked to about 8% of all
hospital-acquired infections in the USA. This structure provides the foundation
for further investigations into this divergent member of the OB-fold family.
1. Introduction
KPN03535 (gi|152972051) is an orphan protein that is exclusively
found in Klebsiella pneumoniae MGH 78578 (an opportunistic
human pathogen belonging to enterbacteriales of gammaproteo-
bacteria; Galperin et al., 2007; Gill et al., 2006; Frank & Pace, 2008;
Ley et al., 2008) and K. pneumoniae 342 (three-residue substitution).
It consists of 132 residues with a calculated pI of 9.40 and a predicted
signal peptide. The N-terminus of KPN03535 has a lipoprotein
signature, indicated by the presence of an LSGC motif (von Heijne,
1989), as well as predictions from LipoP 1.0 (Juncker et al., 2003). It is
a singleton protein that has not been assigned to any Pfam family, but
sequence-based fold-prediction methods (Ginalski et al., 2003)
suggest similarity to members of the PF01336 family (OB-fold nucleic
acid-binding domain). We determined the crystal structure of
KPN03535 in order to explore this extremely divergent member of
the commonly occurring OB-fold. Structural comparisons show
similarities to the OB-fold-containing Cpx-pathway protein NlpE,
single-stranded DNA-binding (SSB) proteins, bacterial OB-fold
(BOF) and toxin proteins, which enable inferences about function
that may now be tested biochemically. This structure should serve as a
basis for understanding structure–function relationships in any newly
discovered proteins with a similar sequence, such as those identiﬁed
by whole microbial genome sequencing and metagenomic surveys of
the human microbiome.
2. Materials and methods
2.1. KPN03535 expression, purification and crystallization
Clones were generated using the Polymerase Incomplete Primer
Extension (PIPE; Klock et al., 2008) cloning method. The gene
encoding KPN03535 (gi|152972051; Swiss-Prot A6TEE6) was
ampliﬁed by polymerase chain reaction (PCR) from K. pneumoniae
MGH 78578 genomic DNA using PfuTurbo DNA polymerase
(Stratagene) and I-PIPE (Insert) primers (forward primer, 50-ctgtac-
ttccagggcGCTTCTAAAGCCTTTTATTCCGCGGGAG-30; reverse
primer, 50-aattaagtcgcgttaTTTAACCACCTTGGGATTCTGTAGC-
GTC-30; target sequence in upper case) that included sequences for
the predicted 50- and 30-ends. The expression vector, pSpeedET,
which encodes an amino-terminal tobacco etch virus (TEV) protease-
cleavable expression and puriﬁcation tag (MGSDKIHHHHHHEN-LYFQG), was PCR-ampliﬁed with V-PIPE (Vector) primers (forward
primer, 50-taacgcgacttaattaactcgtttaaacggtctccagc-30; reverse primer,
50-gccctggaagtacaggttttcgtgatgatgatgatgatg-30). V-PIPE and I-PIPE
PCR products were mixed to anneal the ampliﬁed DNA fragments
together. Escherichia coli GeneHogs (Invitrogen) competent cells
were transformed with the V-PIPE/I-PIPE mixture and dispensed on
selective LB-agar plates. The cloning junctions were conﬁrmed by
DNA sequencing. Using the PIPE method, the gene segment
encoding residues Met1–Leu22 was deleted for expression of soluble
protein as these residues were initially predicted to correspond to
either a signal peptide using SignalP (Bendtsen et al., 2004) or
transmembrane helices using TMHMM-2.0 (Krogh et al., 2001).
Expression was performed in selenomethionine-containing medium.
At the end of fermentation, lysozyme was added to the culture to a
ﬁnal concentration of 250 mgm l
 1 and the cells were harvested and
frozen. After one freeze–thaw cycle, the cells were homogenized in
lysis buffer [50 mM HEPES pH 8.0, 50 mM NaCl, 10 mM imidazole,
1m M tris(2-carboxyethyl)phosphine–HCl (TCEP)] and the lysate
was clariﬁed by centrifugation at 32 500g for 30 min. The soluble
fraction was passed over nickel-chelating resin (GE Healthcare) pre-
equilibrated with lysis buffer, the resin was washed with wash buffer
[50 mM HEPES pH 8.0, 300 mM NaCl, 40 mM imidazole, 10%(v/v)
glycerol, 1 mM TCEP] and the protein was eluted with elution buffer
[20 mM HEPES pH 8.0, 300 mM imidazole, 10%(v/v) glycerol, 1 mM
TCEP]. The eluate was buffer-exchanged with TEV buffer (20 mM
HEPES pH 8.0, 200 mM NaCl, 40 mM imidazole, 1 mM TCEP) using
a PD-10 column (GE Healthcare) and incubated with 1 mg TEV
protease per 15 mg of eluted protein. The protease-treated eluate was
passed over nickel-chelating resin (GE Healthcare) pre-equilibrated
with HEPES crystallization buffer (20 mM HEPES pH 8.0, 200 mM
NaCl, 40 mM imidazole, 1 mM TCEP) and the resin was washed with
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Table 1
Crystallographic data and reﬁnement statistics for KPN03535 (PDB code 3f1z).
Values in parentheses are for the highest resolution shell.
Space group P212121
Unit-cell parameters (A ˚ ) a = 97.42, b = 105.51, c = 181.25
Data collection
Wavelength (A ˚ ) 0.9792 [Se peak ( 1)]
Resolution range (A ˚ ) 29.9–2.46 (2.52–2.46)
No. of observations 509996
No. of unique reﬂections 68362
Completeness (%) 99.8 (99.7)
Mean I/ (I) 15.4 (2.5)
Rmerge on I† (%) 11.1 (69.6)
Model and reﬁnement statistics
Resolution range (A ˚ ) 29.9–2.46
No. of reﬂections (total) 68310‡
No. of reﬂections (test) 3458
Completeness (%) 99.7
Data set used in reﬁnement  1
Cutoff criterion |F|>0
Rcryst§ 0.192
Rfree§ 0.228
Stereochemical parameters
Restraints (r.m.s.d. observed)
Bond angle ( ) 1.70
Bond length (A ˚ ) 0.017
Average isotropic B value (A ˚ 2) 38.2}
ESU†† based on Rfree (A ˚ ) 0.22
Protein residues/atoms 1182/9162
Water/PEG molecules 323/2
† Rmerge =
P
hkl
P
i jIiðhklÞ h IðhklÞij=
P
hkl
P
i IiðhklÞ. ‡ Typically, the number of
unique reﬂections used in reﬁnement is slightly less than the total number that were
integrated and scaled. Reﬂections are excluded owing to systematic absences, negative
intensities and rounding errors in the resolution limits and unit-cell parameters. § Rcryst
=
P
hkl
   jFobsj j Fcalcj
   =
P
hkl jFobsj, where Fcalc and Fobs are the calculated and observed
structure-factor amplitudes, respectively. Rfree is as for Rcryst, but for 5.1% of the total
reﬂections chosen at random and omitted from reﬁnement. } This value represents the
total B that includes TLS and residual B components. †† ESU, estimated overall
coordinate error (Collaborative Computational Project, Number 4, 1994; Tickle et al.,
1998).
Figure 1
Crystal structure of KPN03535. (a) Stereo ribbon representation of the KPN03535 monomer color-coded from the N-terminus (yellow) to the C-terminus (green). The
nomenclature for helix   and strands  1– 5 follows that used for the OB-fold (Murzin, 1993). Helices   2,   1 and  0 are unique to KPN03535. (b) Diagram showing the
secondary-structure elements of KPN03535 superimposed on the primary amino-acid sequence. Helices and  -strands are indicated. The protein was expressed with a
puriﬁcation tag that was removed, leaving a residual Gly residue at the N-terminus followed by the KPN03535 sequence.the same buffer. The ﬂowthrough and wash fractions were combined
and concentrated for crystallization trials to 16.1 mg ml
 1 by centri-
fugal ultraﬁltration (Millipore). KPN03535 was crystallized by mixing
100 nl protein solution with 100 nl crystallization solution in a sitting
drop over a 50 ml reservoir volume using the nanodroplet vapor-
diffusion method (Santarsiero et al., 2002) with standard Joint Center
for Structural Genomics (JCSG; http://www.jcsg.org) crystallization
protocols (Lesley et al., 2002). The crystallization reagent contained
31% polyethylene glycol 600 and 0.1 M CHES pH 9.5. No further
cryoprotectant was added to the crystal. A cube-shaped crystal with
approximate dimensions 80   80   80 mm was harvested after 42 d at
293 K for data collection. Initial screening for diffraction was carried
out using the Stanford Automated Mounting system (SAM; Cohen et
al., 2002) at the Stanford Synchrotron Radiation Lightsource (SSRL;
Menlo Park, California, USA). The diffraction data were indexed in
the orthorhombic space group P212121. The molecular weight and
oligomeric state were determined using a 1   30 cm Superdex 200
column (GE Healthcare) in combination with static light scattering
(Wyatt Technology). The mobile phase consisted of 20 mM Tris pH
8.0, 150 mM NaCl and 0.02%(w/v) sodium azide.
2.2. X-ray data collection and structure determination
Single-wavelength anomalous diffraction (SAD) data were
collected to 2.46 A ˚ resolution on beamline 9-2 at SSRL at the
wavelength corresponding to the peak ( 1) of a selenium absorption
edge using the Blu-Ice data-collection environment (McPhillips et al.,
2002). A data set was collected at 100 K using a MAR Mosaic 325
CCD detector (Rayonix USA). The SAD data were integrated and
reduced using MOSFLM (Leslie, 1992) and scaled with the program
SCALA (Collaborative Computational Project, Number 4, 1994).
Phasing was performed with SHELXD (Sheldrick, 2008) and auto-
SHARP (Vonrhein et al., 2007) [20 selenium sites per asymmetric
unit, overall FOM (acentric/centric) = 0.34/0.12, overall phasing
power (anomalous differences) = 1.2] and automated iterative model
building was performed with RESOLVE (Terwilliger, 2003). Model
completion and crystallographic reﬁnement were performed with
Coot (Emsley & Cowtan, 2004) and REFMAC5 (Collaborative
Computational Project, Number 4, 1994) with TLS (one group per
monomer) reﬁnement (Winn et al., 2003) and medium NCS restraints
for all chains. Data and reﬁnement statistics are summarized in
Table 1.
The quality of the crystal structure was analyzed using the JCSG
Quality Control server, which veriﬁes the stereochemical quality of
the model using AutoDepInputTool (Yang et al., 2004), MolProbity
(Davis et al., 2004) and WHATIF 5.0 (Vriend, 1990), the agreement
between the atomic model and the data using SFCHECK 4.0
(Vaguine et al., 1999) and RESOLVE (Terwilliger, 2000), the protein
sequence using ClustalW (Thompson et al., 1994), atom occupancies
using MOLEMAN2 (Kleywegt, 2000) and the consistency of NCS
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Figure 2
Superimposition of the crystal structure of KPN03535 (red) on OB-fold proteins that have N-terminal lipoprotein sequence, such as (a) NlpE, (b) shiga toxin and (c) BOF,
and single-stranded DNA-binding proteins (SSBs), such as (d) E. coli SSB, (e) E. coli PriB and (f) T. thermophilus aspartyl-tRNA synthetase.pairs. This analysis also evaluates difference in Rcryst/Rfree, expected
Rfree/Rcryst and maximum/minimum B values by parsing the reﬁne-
ment log-ﬁle and PDB header. Protein quaternary structure analysis
was performed using the PISA server (Krissinel & Henrick, 2005).
Fig. 1(b) was adapted from an analysis using PDBsum (Laskowski et
al., 2005) and all other ﬁgures were prepared with PyMOL (DeLano,
2002). Atomic coordinates and experimental structure factors for
KPN03535 have been deposited in the PDB under accession code
3f1z. A systematic search for other proteins of similar structure was
conducted using several different methods including the DALI server
(Holm et al., 2008), the protein structure comparison service SSM at
the European Bioinformatics Institute (http://www.ebi.ac.uk/msd-srv/
ssm; Krissinel & Henrick, 2004) and the ﬂexible structure-alignment
method FATCAT (Ye & Godzik, 2003).
3. Results and discussion
3.1. Overall structure
Residues 1–22 of the full-length protein (1–154) were initially
predicted to represent a signal peptide and were removed during
cloning. The crystallized protein is comprised of a glycine left after
cleavage of the expression and puriﬁcation tag followed by
KPN03535 residues 23–154. The ﬁnal model contains ten monomers
(chains A–J), two PEG molecules (PEG 600 fragments from the
crystallization solution) and 323 water molecules in the asymmetric
unit. The ten monomers are almost identical in structure and
completeness and superimpose extremely well, with pairwise r.m.s.d.
values ranging from only 0.2 to 0.4 A ˚ . Residues 23–35 in chains AB ,
C, E and J, 23–36 and 154 in chain D, 23–35 and 154 in chain F, 23–36
in chains G and H, and 23–38 in chain I and the N-terminal glycine in
all chains are disordered and have not been modeled. The Matthews
coefﬁcient (Matthews, 1968) is  3.2 A ˚ 3 Da
 1, with an estimated
solvent content of  62%. The Ramachandran plot produced by
MolProbity (Davis et al., 2004) shows that 98.5% and 100% of amino
acids are in the favored and allowed regions, respectively.
Residues 70–154 of the monomer form the OB-fold comprised of a
ﬁve-stranded  -sheet ( 1,  2,  3,  4 and  5) capped by a short
 -helix ( ) based on the standard OB-fold nomenclature (Murzin,
1993; Fig. 1a). The capping helix is shorter than those observed in
most other OB-fold proteins (Fig. 2). Residues 36–69 constitute three
additional  -helices (  2,   1 and  0) which are not observed in
other structures of the same fold. The curved  -sheet forming the
 -barrel core of the OB-fold is highly conserved in size and structure,
while the largest variations are seen in the three loops (L12,L 23 and
L45) that extend in different directions from the core and are often
functionally important.
Crystal-packing and assembly analysis using PISA (Krissinel &
Henrick, 2005) supported by analytical size-exclusion chromato-
graphy and static light scattering suggest that a monomer is the likely
oligomeric state. In the crystal structure, the protein assembles as two
stacked pentameric rings, formed by loose interdigitation of the
‘ﬁnger-like’  1–L12– 2 structure, with outer and inner diameters of
 80 A ˚ and  40 A ˚ , respectively, and a thickness of  40 A ˚ . The buried
surface area of each monomer within each pentamer ( 540 A ˚ 2) and
each monomer in the interface between the two pentamers
( 600 A ˚ 2) is low. The quaternary structure analysis does not suggest
sufﬁciently strong and extensive interactions to enable complex
formation in solution, suggesting that these pentamers could be a
crystallization artifact. The N-terminus of each monomer extends
into the solvent and probably does not have an impact on the
oligomerization state. In the absence of any biochemical data, the
functional oligomeric state of the protein remains unknown.
3.2. Functional hypotheses
3.2.1. NlpE-like. The only other reported bacterial lipoprotein
containing an OB-fold is the C-terminal domain of E. coli NlpE (new
lipoprotein E), which is an outer membrane lipoprotein in Gram-
negative bacteria involved in the envelope stress response in the Cpx
pathway. It activates the Cpx, two-component, signal transduction
pathway composed ofthe inner membrane histidine kinase CpxA and
the cytoplasmic response regulator CpxR (Raivio & Silhavy, 1997).
The Cpx pathway controls the production of the periplasmic protease
DegP and other proteins involved in ﬁghting cellular stress (Snyder et
al., 1995; Danese et al., 1995; Raivio et al., 1999). Other proteins are
also implicated in the regulation of the Cpx pathway. For example,
CpxP with an LTXXQ motif (Pfam PF07813) is involved in feedback
inhibition of the Cpx pathway (Danese et al., 1998; Danese & Silhavy,
1998). In K. pneumoniae, a periplasmic CpxP-like protein with the
LTXXQ motif, KPN03534, is the neighboring gene to KPN03535.
Therefore, KPN03535, like KPN03534, may play a role in the Cpx
pathway, similar to NlpE. KPN03535 superimposes fairly well on
E. coli NlpE (PDB code 2z4i; Hirano et al., 2007; r.m.s.d.= 3.3 A ˚ , 16%
sequence identity, Z score 2.3; Fig. 2a). Despite extremely low
sequence identity, some residues are conserved in KPN03535 (Arg76,
Asp100, Thr105, Lys107, Arg108 and Asn117) from structure-based
sequence alignment. However, the functional roles of these residues
in NlpE are not known.
3.2.2. Toxin and BOF-like. Other bacterial OB-fold proteins that
have an N-terminal signal sequence are toxins, such as the shiga toxin
(PDB code 1r4p; Fraser et al., 2004; Fig. 2b), cholera toxin (PDB code
3efx; Holmner et al., 2004; r.m.s.d. = 2.8 A ˚ , 6% sequence identity, Z
score 5.8) and a bacterial OB-fold (BOF; Ginalski et al., 2004) protein
structural communications
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Figure 3
Surface-exposed charged and aromatic residues on KPN03535 that may be
functionally important if this protein binds DNA or RNA (for clarity, the view of
the monomer shown here is different from that shown in Fig. 4 and was obtained by
a 180  rotation around a horizontal axis followed by a 180  rotation around a
vertical axis). Arg83, Arg84 and Lys85 comprise the positive surface region
described in Fig.4.Arg84 and Lys85 are conserved as Arg17 andLys18 inthe E.coli
PriB structure and as Arg29 in T. thermophilus aspartyl-tRNA synthetase. Phe94 is
conserved in shiga toxin, but there are currently no reports of any functional role of
this residue in the toxin.(1nnx; O. Lehmann, A. Galkin, S. Pullalarevu, E. Sarikaya, W.
Krajewski, K. Lim, A. Howard & O. Herzberg, unpublished work;
r.m.s.d. = 2.9 A ˚ , 14% sequence identity; Z score 7.4; Fig. 2c). Neither
NlpE nor the toxins have all three of the N-terminal helices ( 0,   1,
  2) found in KPN03535, but   2 is observed in cholera toxin (3efx)
and   1 is observed in BOF protein (1nnx). The capping helix   in
KPN03535 is shorter than in the toxins and NlpE, although it is
similar to that observed in BOF protein. The  -strands forming the
curved  -barrel in all these structures are of similar length, but with
differences in the loop sizes that connect the  -strands.
3.2.3. Single-stranded DNA-binding protein, SSB-like. Single-
stranded DNA-binding proteins (SSBs) also possess OB-folds and
are involved in a multitude of cellular functions, such as DNA
replication, transcription, recombination, repair, translation, cold-
shock response and maintenance of telomeres (Theobald et al., 2003;
Chase & Williams, 1986; Wold, 1997; Meyer & Laine, 1990; Lohman
& Ferrari, 1994; Lohman et al., 1996). KPN03535 is structurally
similar to OB-fold SSBs, including E. coli SSB (PDB code 1eyg;
Raghunathan et al., 2000; r.m.s.d. 2.7 A ˚ ; 13% sequence identity; Z
score 7.0; Fig. 2d), E. coli PriB (PDB code 1v1q; Liu et al., 2004;
r.m.s.d. 2.3 A ˚ ; 13% sequence identity, Z score 8.0; Fig. 2e), Thermus
thermophilus aspartyl-tRNA synthetase (PDB code 1l0w; Ng et al.,
2002; r.m.s.d. 2.6 A ˚ ; 11% sequence identity; Z score 9.0; Fig. 2f) and
human mitochondrial SSB (PDB code 3ull; Yang et al., 1997; r.m.s.d.
structural communications
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Figure 4
Comparison of the electrostatic surface potentials of monomers of (a) NlpE, (b) shiga toxin, (c) BOF, (d) E. coli SSB, (e) E. coli PriB, (f) T. thermophilus aspartyl-tRNA
synthetase and (g) KPN03535. All the ﬁgures are in approximately the same orientation and reﬂect the surface view that would be presented for oligonucleotide binding, as
in tRNA synthetase. The ﬁgure reveals that the positively charged surface patch (central blue portion in black circles) on the KPN03535 most closely resembles that of E. coli
PriB and is also similar to that seen in aspartyl-tRNA synthetase. In KPN03535, this positively charged patch is formed by Arg83, Arg84 and Lys85. The corresponding
conserved residues are Arg17 and Lys18 in PriB and Arg29 in aspartyl-tRNA synthetases, respectively.2.7 A ˚ ; 8% sequence identity, Z score 7.1). The N-terminal   1 and 0
secondary-structure elements in KPN03535 are partially conserved in
aspartyl-tRNA synthetase, but not in the other structures. Many of
the loops in OB-fold ssDNA-binding proteins are either involved in
interactions with DNA or in quaternary interactions that result in the
various oligomeric forms. For example, loop L45, which makes the
most interactions with DNA in PriB (Huang et al., 2006) and aspartyl-
tRNA synthetase, is similar to that of KPN03535, but is much longer
in E. coli and in human mitochondrial SSBs. Among the surface-
exposed Arg, Lys and aromatic residues that could be functionally
relevant if KPN03535 were to bind DNA or RNA (Fig. 3), Arg84 and
Lys85 of KPN03535 are conserved and correspond to Arg17 and
Lys18 in PriB, where Lys18 is involved in ssDNA-binding (Huang et
al., 2006). Arg83 and Arg99 of KPN03535 are conserved in aspartyl
tRNA synthetase as Arg29 (equivalent to Arg28 in the E. coli
aspartyl-tRNA synthetase that binds to tRNA; Eiler et al., 1999) and
Arg39. Multiple structural alignment of various OB-fold proteins
using the POSA method (Ye & Godzik, 2005) suggests that
KPN03535 has a closer relationship to tRNA synthetases than to the
BOF protein and is most distant from OB-fold toxins.
Analysis of the electrostatic surface potential indicates that
KPN03535 most closely resembles PriB and aspartyl-tRNA synthe-
tase (Fig. 4), with a prominent positively charged area similar to the
DNA-binding region of these two proteins. Interestingly, this patch is
different from that observed in the E. coli SSB, which reﬂects the
known differences in ssDNA-binding modes of SSB and PriB. The
basic nature of KPN03535 (pI 9.4) also hints at the possibility of
oligonucleotide binding.
In conclusion, the crystal structure of KPN03535 reveals a novel
divergent member of the prevalent OB-fold and suggests that it is
most likely to be a nucleic acid-binding protein. As for the recently
solved structure of MPN554 from Mycoplasma pneumoniae (Das et
al., 2007), another novel OB-fold with unknown cellular function but
with single-stranded DNA-binding properties, the structure of
KPN03535 reveals that further exploration of the functionality of the
OB-fold is necessary. Bacterial lipoproteins have many important
functions and are potential vaccine candidates (Steere et al., 1998;
Myers etal., 2007). K.pneumoniae is an opportunistic pathogen that is
prevalent in immunocompromised patients in hospitals and in
patients with liver disease (Hidron et al., 2008; Pope et al., 2008).
Functional inferences that can be drawn from this crystal structure
should now allow focused structure-assisted biochemistry to establish
the exact molecular and cellular role for this protein.
Additional information about KPN03535 is available from
TOPSAN (Krishna et al., 2010) http://www.topsan.org/explore?PDBid
=3f1z.
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